What Is Hodgkin Lymphoma?

Kristin L. Walter

doi:10.1001/jama.2026.16940

Medicine & healthCancer care

What Is Hodgkin Lymphoma?

Kristin L. Walter

Peer-reviewed journalBroad interestEasy to read

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result

This JAMA Patient Page describes the risk factors, symptoms, and diagnosis of Hodgkin lymphoma along with treatment details and prognosis.

Read the paper

Appeared: Saturday, September 26. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.16940

Medicine & health Cancer care Sep 26, 2026
Direct Pan-Cancer Multi-Omic Analysis of Radiotherapy Response Reveals Coding and Regulatory Genomic Variation, and Extracellular Adaptive Programs Underlying Radioresistance
To our knowledge, this study provides the first pan-cancer characterisation of clinically defined radiotherapy response and identifies potential candidate biomarkers for functional validation.
K. Raman, S. C. Yadla, P. Ravi and 1 more — medRxiv
PreprintClaims a big step
Medicine & health Cancer care Sep 26, 2026
Adaptive nuclear GTP synthesis promotes glioblastoma treatment resistance and is a targetable vulnerability in patients
Together, these findings implicate IMPDH as a potential metabolic target in GBM whose pharmacological inhibition is feasible and could complement standard-of-care chemoradiation therapy.
N. Liang, A. J. Scott, W. N. Al-Holou and 37 more — medRxiv
PreprintReal-world use
Medicine & health Cancer care Sep 26, 2026
Spatiotemporal delivery of immune-synapse-stabilizing NK cells for postoperative tumor therapy
Here, Li and colleagues report that arming NK cells with surface-anchored, multivalent galectin-3 binding polymers prolongs NK-to-tumor target cell contact and enhances NK cytotoxicity; as well, authors describe that a semi-spike patch for spatiotemporal delivery of armed NK cells in the resection cavity prevents tumor recurrence post-surgery.
Junzhu Shi, Junlin Li, Ping Zhang and 7 more — Nature Communications
Peer-reviewed journalBold claims, read criticallyReal-world use
Medicine & health Cancer care Sep 26, 2026
Alternative PFAS Are Associated with Ovarian Cancer-Related Lipidomic Remodeling and Cross-Matrix Metabolic Signatures
Collectively, these findings demonstrate that both alternative and emerging PFAS are associated with a distinct OC-related molecular phenotype involving coordinated lipidomic, metabolomic, and hematologic alterations, while highlighting DONA and GenX as the most prominent exposure-related signals.
H. Liu, J. Ni, N. Gao and 5 more — medRxiv
Preprint
Medicine & health Cancer care Sep 26, 2026
Quantitative Systems Pharmacology Model for Trop-2 Targeting Antibody-Drug Conjugate in Triple-Negative Breast Cancer
Overall, this QSP framework for TROP2-targeted ADCs accounts for TNBC heterogeneity and is extendable to other ADCs and targets enabling interrogation of ADC mechanisms of action in conjunction with tumor-immune interactions.
S. Dogru, A. Suresh, E. P. Bowman and 3 more — bioRxiv
PreprintReal-world use

All new papers on Cancer care

What Is Hodgkin Lymphoma?

In the authors' words

More on Cancer care that day

Direct Pan-Cancer Multi-Omic Analysis of Radiotherapy Response Reveals Coding and Regulatory Genomic Variation, and Extracellular Adaptive Programs Underlying Radioresistance

Adaptive nuclear GTP synthesis promotes glioblastoma treatment resistance and is a targetable vulnerability in patients

Spatiotemporal delivery of immune-synapse-stabilizing NK cells for postoperative tumor therapy

Alternative PFAS Are Associated with Ovarian Cancer-Related Lipidomic Remodeling and Cross-Matrix Metabolic Signatures

Quantitative Systems Pharmacology Model for Trop-2 Targeting Antibody-Drug Conjugate in Triple-Negative Breast Cancer